Product Images Gabapentin

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 7 images provide visual information about the product associated with Gabapentin NDC 71205-514 by Proficient Rx Lp, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

71205-514-60 - gabapentin 800mg 30tab

71205-514-60 - gabapentin 800mg 30tab

This is a description of a medication called Gabapentin 800mg. It comes in a 90 tablet package and its main ingredient is gabapentin, USP. It has a white to off-white color, is capsule-shaped and is scored, some tablets are debossed with “SG" on one side and 178" on the other side with bisect line. Gabapentin is packaged by Proficient Rx LP and distributed by ScieGen Pharmaceuticals, Inc. Patients who take this medication should be provided with a medication guide. This medication should be kept at a temperature of between 20°C and 25°C, and out of the reach of children. The lot number is 00000, and the expiration date is 000000.*

Figure 1 - image 01

Figure 1 - image 01

This is a chart displaying the mean pain score of a study. It compares the pain scores of a placebo group and a group taking gabapentin at 3600 mg/day, in both a fixed dose period and a titration period. The chart shows baseline data and data collected over the course of several weeks.*

Figure 2 - image 02

Figure 2 - image 02

This is a graph showing the results of a study with a 4-week fixed dose period on the effect of Gabapentin to reduce pain score compared to a Placebo. The Gabapentin groups were given a dose of either 1800mg/day or 2400mg/day. The X-axis shows the weeks and the Y-axis shows the mean pain score.*

Figure 3 - image 03

Figure 3 - image 03

image-04 - image 04

image-04 - image 04

Gabapentin Structural Formula - image 05

Gabapentin Structural Formula - image 05

Figure 4. Responder Rate in Patients Receiving gabapentin Expressed as a Difference from Placebo by Dose and Study: Adjunctive Therapy Studies in Patients ≥12 Years of Age with Partial Seizures - image 09

Figure 4. Responder Rate in Patients Receiving gabapentin Expressed as a Difference from Placebo by Dose and Study: Adjunctive Therapy Studies in Patients ≥12 Years of Age with Partial Seizures - image 09

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.